These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2438401)

  • 1. Effects of a 5-lipoxygenase inhibitor, REV-5901, on leukotriene and histamine release from human lung tissue in-vitro.
    Tennant CM; Seale JP; Temple DM
    J Pharm Pharmacol; 1987 Apr; 39(4):309-11. PubMed ID: 2438401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by REV-5901 of leukotriene release from guinea-pig and human lung tissue in vitro.
    Kusner EJ; Marks RL; Aharony D; Krell RD
    Biochem Pharmacol; 1989 Dec; 38(23):4183-9. PubMed ID: 2557041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the release of leukotrienes and histamine by human lung parenchymal and bronchial fragments upon immunologic and nonimmunologic stimulation. Effects of nordihydroguaiaretic acid, aspirin, and sodium cromoglycate.
    Salari H; Borgeat P; Fournier M; Hebert J; Pelletier G
    J Exp Med; 1985 Dec; 162(6):1904-15. PubMed ID: 2415659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of REV 5901, a 5-lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea-pig.
    Anderson G; Fennessy M
    Br J Pharmacol; 1988 Aug; 94(4):1115-22. PubMed ID: 3145088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial salvage induced by REV-5901: an inhibitor and antagonist of the leukotrienes.
    Mullane K; Hatala MA; Kraemer R; Sessa W; Westlin W
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):398-406. PubMed ID: 2444792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5-lipoxygenase inhibition on cardiac anaphylaxis in isolated guinea pig hearts.
    Jolly SR; Travis J; Van Inwegen RG
    Pharmacology; 1989; 38(6):352-62. PubMed ID: 2813496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta-adrenoceptor antagonists.
    Hughes JM; Seale JP; Temple DM
    Eur J Pharmacol; 1983 Nov; 95(3-4):239-45. PubMed ID: 6197312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of non-steroidal inhibitors of phospholipase A2 on leukotriene and histamine release from human and guinea-pig lung.
    Kench JG; Seale JP; Temple DM; Tennant C
    Prostaglandins; 1985 Aug; 30(2):199-208. PubMed ID: 2413502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the new 5-lipoxygenase inhibitor E6080 on leukotriene release in vitro.
    Sakuma Y; Katayama S; Tsunoda H; Abe S; Yamatsu I; Katayama K
    Int Arch Allergy Immunol; 1992; 97(4):267-73. PubMed ID: 1375926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nedocromil sodium inhibits antigen-induced contraction of human lung parenchymal and bronchial strips, and the release of sulphidopeptide-leukotriene and histamine from human lung fragments.
    Napier FE; Shearer MA; Temple DM
    Br J Pharmacol; 1990 Jun; 100(2):247-50. PubMed ID: 1696152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loratadine, an antihistamine, blocks antigen-and ionophore-induced leukotriene release from human lung in vitro.
    Temple DM; McCluskey M
    Prostaglandins; 1988 Apr; 35(4):549-54. PubMed ID: 2470117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition by azatadine of the immunological release of leukotrienes and histamine from human lung fragments.
    Daniels C; Temple DM
    Eur J Pharmacol; 1986 Apr; 123(3):463-5. PubMed ID: 2424773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mammalian 5-lipoxygenase by 2-benzylaminophenols.
    Buckle DR; Bumstead J; Clarke GD; Foster KA; Parr H; Taylor JF; Thody VE; Webster RA
    Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):29-33. PubMed ID: 3186776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of human mast cells and basophils. Effects of a putative 5-lipoxygenase inhibitor.
    Cohan V; McKenzie-White J; Triggiani M; Massey W; Kagey-Sobotka A; Lichtenstein LM
    Biochem Pharmacol; 1989 Dec; 38(24):4455-9. PubMed ID: 2481451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulus-dependence and time-course of histamine and leukotriene release from chopped and dispersed human lung tissue.
    Sydbom A; Kumlin M; Dahlén SE
    Agents Actions; 1987 Apr; 20(3-4):198-201. PubMed ID: 2440270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of arachidonic acid metabolism on the release of histamine and SRS (leukotrienes) from guinea-pig lung.
    Chakravarty N
    Agents Actions; 1984 Apr; 14(3-4):429-34. PubMed ID: 6203364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of arachidonate lipoxygenase in the release of SRS-A from guinea-pig chopped lung.
    Morris HR; Piper PJ; Taylor GW; Tippins JR
    Prostaglandins; 1980 Mar; 19(3):371-83. PubMed ID: 6155680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of the 5-lipoxygenase inhibitor phenidone on antigen-induced release of histamine in vitro].
    Sauer RR; Sauer CI; Merk H; Steigleder GK
    Z Hautkr; 1987 Aug; 62(15):1175-8. PubMed ID: 2445116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential inhibition of 5-lipoxygenase activity by manoalide.
    De Vries GW; Amdahl L; Mobasser A; Wenzel M; Wheeler LA
    Biochem Pharmacol; 1988 Aug; 37(15):2899-905. PubMed ID: 2840081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor.
    Ashida Y; Saijo T; Kuriki H; Makino H; Terao S; Maki Y
    Prostaglandins; 1983 Dec; 26(6):955-72. PubMed ID: 6084855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.